Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis

PURPOSE: To report the first patient with ocular toxoplasmosis treated with a slow-release biodegradable intravitreal clindamycin implant. OBSERVATIONS: A 39-year-old human immunodeficiency virus (HIV)-positive woman with recurrent toxoplasmic retinochoroiditis and vitritis for whom oral medication...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Ophthalmol Case Rep
Autors principals: Jorge, Rodrigo, Coelho, Igor Neves, Silva-Cunha, Armando, Fernandes Cunha, Gabriella Maria, Scott, Ingrid U., Fialho, Silvia Ligório, Furtado, João Marcello
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8085661/
https://ncbi.nlm.nih.gov/pubmed/33981913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2021.101093
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars